• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Envoke

To add a bio or update company history, please click update information.

News from Envoke

    Envoke lands £1.6m from VCs for lab equipment training and maintenance softwareEnvoke lands £1.6m from VCs for lab equipment training and maintenance software
    Envoke
    12 May 2026

    Envoke lands £1.6m from VCs for lab equipment training and maintenance software

    Envoke develops software that creates virtual replicas of laboratory equipment for remote training, troubleshooting and maintenance. The platform helps healthcare providers and equipment manufacturers reduce downtime, improve staff training and cut servicing costs.

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staffEnvoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff
    Envoke
    19 May 2025

    Envoke raises £1m seed extension from Mercia to expand virtual training platform for lab staff

    Envoke builds virtual training software for laboratory equipment, allowing staff to learn, practise and troubleshoot using realistic digital simulations and remote support tools.

Envoke
  • Life Sciences
  • Leeds, United Kingdom
  • £2.6m
  • envoke-demos.com
  • Update Information

More venture news

  • Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
    Revolver Therapeutics
    6 Jul 2026

    Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins

    EquityLife Sciences
  • RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
    RQ Bio
    25 Jun 2026

    RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza

    Series ALife Sciences
  • TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
    TRIMTECH Therapeutics
    23 Jun 2026

    TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases

    ExtensionLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn